Comparison
Huperzine A vs DMAE
Huperzine A
Potent acetylcholinesterase inhibitor derived from Chinese club moss. Studied for Alzheimer's treatment in China.
DMAE
Dimethylaminoethanol — a choline precursor with mild stimulant effects. Found naturally in sardines and anchovies.
| Field | Huperzine A | DMAE |
|---|---|---|
| Category | cholinergic | cholinergic |
| Dose range | 0.05–0.2mg | 100–500mg |
| Half-life | 12h | 4h |
| Onset | 60min | — |
| Evidence | EVIDENCEA | EVIDENCEC |
| Safety | ●●●○○ | ●●●●○ |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 380 | 110 |
The comparison in plain English
Auto-generated from dataHuperzine A and DMAE are both in the cholinergic category respectively. Huperzine A Potent acetylcholinesterase inhibitor derived from Chinese club moss. DMAE Dimethylaminoethanol — a choline precursor with mild stimulant effects.
Bottom line
Huperzine A (evidence A, safety 3/5) has a weaker evidence base than DMAE (evidence C, safety 4/5). DMAE has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Huperzine A if
Huperzine A is the better fit when your goal aligns with its mechanism (Reversibly inhibits acetylcholinesterase, preventing the breakdown of acetylcholine in synaptic clefts and prolonging cholinergic signalling) and the dose range (0.05–0.2mg) suits your protocol. Half-life is 12h.
Choose DMAE if
DMAE is the better fit when your goal aligns with its mechanism (Crosses the blood-brain barrier and is metabolised to choline, supporting acetylcholine synthesis) and the dose range (100–500mg) suits your protocol. Half-life is 4h.